EMILY JENSON: Open Payments
NPI 1932641594 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 29 payments from 13 companies in 2025. Trend: 2023 $1,007 · 2024 $865 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $112 |
| Galderma Laboratories, L.P. | 3 | $84 |
| PFIZER INC. | 5 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Amgen Inc. | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $45 |
| Organon LLC | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
Products named: DUPIXENT, NEMLUVIO, CIBINQO, OTEZLA, COSENTYX, TREMFYA, VTAMA, Rhapsido.
Industry payments across AZ — which companies pay providers there.
